Benefits
Bone strength
In a 3-year randomized trial in postmenopausal women, low-dose MK-7 helped decrease age-related bone loss, supporting bone mineral density.
Arterial flexibility
Vitamin K2 activates a protein that keeps calcium out of artery walls, supporting flexible, healthy arteries.
Calcium routing
MK-7 helps direct dietary calcium into bone rather than soft tissue, complementing calcium and vitamin D.
Mechanism of action
Osteocalcin activation
MK-7 carboxylates (activates) osteocalcin, the protein that binds calcium into the bone matrix, strengthening bone.
Matrix Gla protein activation
MK-7 activates matrix Gla protein, which inhibits calcium deposition in artery walls, protecting cardiovascular tissue.
Clinical trials
Three-year randomized trial of low-dose menaquinone-7 (MK-7) supplementation in healthy postmenopausal women. (Knapen et al. 2013, Osteoporosis International)
Healthy postmenopausal women.
Low-dose MK-7 helped decrease bone loss at the spine and femoral neck versus placebo.